These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21235457)

  • 1. Current developments in the therapeutic potential of S-nitrosoglutathione, an endogenous NO-donor molecule.
    Hornyák I; Pankotai E; Kiss L; Lacza Z
    Curr Pharm Biotechnol; 2011 Sep; 12(9):1368-74. PubMed ID: 21235457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy.
    Rosales MA; Silva KC; Duarte DA; de Oliveira MG; de Souza GF; Catharino RR; Ferreira MS; Lopes de Faria JB; Lopes de Faria JM
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2921-32. PubMed ID: 24699383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation.
    Wu W; Gaucher C; Diab R; Fries I; Xiao YL; Hu XM; Maincent P; Sapin-Minet A
    Eur J Pharm Biopharm; 2015 Jan; 89():1-8. PubMed ID: 25448077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide generation from S-nitrosoglutathione: New activity of indium and a survey of metal ion effects.
    Lutzke A; Melvin AC; Neufeld MJ; Allison CL; Reynolds MM
    Nitric Oxide; 2019 Mar; 84():16-21. PubMed ID: 30630054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term decomposition of aqueous S-nitrosoglutathione and S-nitroso-N-acetylcysteine: Influence of concentration, temperature, pH and light.
    de Souza GFP; Denadai JP; Picheth GF; de Oliveira MG
    Nitric Oxide; 2019 Mar; 84():30-37. PubMed ID: 30630056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering nitric oxide into human skin from encapsulated S-nitrosoglutathione under UV light: An in vitro and ex vivo study.
    Pelegrino MT; Weller RB; Paganotti A; Seabra AB
    Nitric Oxide; 2020 Jan; 94():108-113. PubMed ID: 31759127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers.
    Sorragi Cde L; Shishido SM; Lemos ME; Marcondes S; Antunes E; Krieger MH
    Cell Biochem Funct; 2011 Apr; 29(3):207-14. PubMed ID: 21374644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin.
    Seabra AB; Fitzpatrick A; Paul J; De Oliveira MG; Weller R
    Br J Dermatol; 2004 Nov; 151(5):977-83. PubMed ID: 15541075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging development of storable particles for oral delivery of a physiological nitric oxide donor.
    Zhou Y; Gaucher C; Fries I; Hobekkaya MA; Martin C; Leonard C; Deschamps F; Sapin-Minet A; Parent M
    Nitric Oxide; 2020 Nov; 104-105():1-10. PubMed ID: 32771473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress enhances and modulates protein S-nitrosation in smooth muscle cells exposed to S-nitrosoglutathione.
    Belcastro E; Wu W; Fries-Raeth I; Corti A; Pompella A; Leroy P; Lartaud I; Gaucher C
    Nitric Oxide; 2017 Sep; 69():10-21. PubMed ID: 28743484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: implications for the treatment of cutaneous leishmaniasis.
    de Souza GF; Yokoyama-Yasunaka JK; Seabra AB; Miguel DC; de Oliveira MG; Uliana SR
    Nitric Oxide; 2006 Nov; 15(3):209-16. PubMed ID: 16527502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione.
    Friedman AJ; Blecher K; Schairer D; Tuckman-Vernon C; Nacharaju P; Sanchez D; Gialanella P; Martinez LR; Friedman JM; Nosanchuk JD
    Nitric Oxide; 2011 Nov; 25(4):381-6. PubMed ID: 21946032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opposite effects of nitric oxide donor, S-nitrosoglutathione, on myocardial ischaemia/reperfusion injury in diabetic and non-diabetic mice.
    Liu Y; Xia C; Wang R; Zhang J; Yin T; Ma Y; Tao L
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):854-861. PubMed ID: 28500760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-nitrosoglutathione.
    Broniowska KA; Diers AR; Hogg N
    Biochim Biophys Acta; 2013 May; 1830(5):3173-81. PubMed ID: 23416062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion Complexation of
    Li W; Wang D; Lao KU; Wang X
    ACS Biomater Sci Eng; 2023 Mar; 9(3):1694-1705. PubMed ID: 36542753
    [No Abstract]   [Full Text] [Related]  

  • 16. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
    Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I
    Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological chemistry and clinical potential of S-nitrosothiols.
    Hogg N
    Free Radic Biol Med; 2000 May; 28(10):1478-86. PubMed ID: 10927172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of nitric oxide donor drugs: s-nitrosothiol tDodSNO is a superior photoactivated donor in comparison to GSNO and SNAP.
    Kumari S; Sammut IA; Giles GI
    Eur J Pharmacol; 2014 Aug; 737():168-76. PubMed ID: 24858367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide releasing Tygon materials: studies in donor leaching and localized nitric oxide release at a polymer-buffer interface.
    Joslin JM; Lantvit SM; Reynolds MM
    ACS Appl Mater Interfaces; 2013 Oct; 5(19):9285-94. PubMed ID: 23957655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the broad-spectrum potential of nitric oxide for antibacterial activity against clinically isolated drug-resistant bacteria.
    Estes Bright LM; Chug MK; Thompson S; Brooks M; Brisbois EJ; Handa H
    J Biomed Mater Res B Appl Biomater; 2024 Jul; 112(7):e35442. PubMed ID: 38923117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.